Abstract
AbstractCOVID-19 patients show heterogeneity in clinical presentation and outcomes that makes pandemic control and strategy difficult; optimizing management requires a systems biology approach of understanding the disease. Here we sought to potentially understand and infer complex disease progression, immune regulation, and symptoms in patients infected with coronaviruses (35 SARS-CoV and 3 SARS-CoV-2 patients and 57 samples) at two different disease progression stages. Further, we compared coronavirus data with healthy individuals (n = 16) and patients with other infections (n = 144; all publicly available data). We applied inferential statistics (the COVID-engine platform) to RNA profiles (from limited number of samples) derived from peripheral blood mononuclear cells (PBMCs). Compared to healthy individuals, a subset of integrated blood-based gene profiles (signatures) distinguished acute-like (mimicking coronavirus-infected patients with prolonged hospitalization) from recovering-like patients. These signatures also hierarchically represented multiple (at the system level) parameters associated with PBMC including dysregulated cytokines, genes, pathways, networks of pathways/concepts, immune status, and cell types. Proof-of-principle observations included PBMC-based increases in cytokine storm-associatedIL6, enhanced innate immunity (macrophages and neutrophils), and lower adaptive T and B cell immunity in patients with acute-like disease compared to those with recovery-like disease. Patients in the recovery-like stage showed significantly enhancedTNF,IFN-γ, anti-viral,HLA-DQA1, andHLA-Fgene expression and cytolytic activity, and reduced pro-viral gene expression compared to those in the acute-like stage in PBMC. Besides, our analysis revealed overlapping genes associated with potential comorbidities (associated diabetes) and disease-like conditions (associated with thromboembolism, pneumonia, lung disease, and septicemia). Overall, our COVID-engine inferential statistics platform and study involving PBMC-based RNA profiling may help understand complex and variable system-wide responses displayed by coronavirus-infected patients with further validation.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference62 articles.
1. World Health Organization, Coronavirus disease 2019 (COVID-19) Weekly epidemiological update. (1 December 2020); https://www.who.int/publications/m/item/weekly-epidemiological-update---1-december-2020.
2. Wong, J. E. L., Leo, Y. S. & Tan, C. C. COVID-19 in Singapore—current experience: critical global issues that require attention and action. JAMA https://doi.org/10.1001/jama.2020.2467 (2020).
3. Kindler, E., Thiel, V. & Weber, F. Interaction of SARS and MERS coronaviruses with the antiviral interferon response. Adv. Virus Res. 96, 219–243 (2016).
4. Shokri, S., Mahmoudvand, S., Taherkhani, R. & Farshadpour, F. Modulation of the immune response by Middle East respiratory syndrome coronavirus. J. Cell Physiol. 234, 2143–2151 (2019).
5. Kikkert, M. Innate immune evasion by human respiratory RNA viruses. J. Innate Immun. 12, 4–20 (2020).